1.
Dual inhibition of PI3K and mTOR in cancer therapy: Mechanisms, clinical potential, and future perspectives. Pharm Pract (Granada) [Internet]. 2026 Mar. 12 [cited 2026 Apr. 15];24(1):1-13. Available from: https://www.pharmacypractice.org/index.php/pp/article/view/3337